A new pancreatic cancer drug is showing promise in clinical trials at Penn. It’s helped one 59-year-old “start living life.”

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis.

A new drug being tested in clinical trials around the world,…